IMV Inc., a clinical stage immuno-oncology company announced that members of the Company’s research and development team will present results from a study at the American Association for Cancer Research Annual Meeting 2019, which is being held March 29 to April 3 in Atlanta, Georgia.
March 12, 2019
· 4 min read